Venous Thromboprophylaxis in Obesity

Anti-Xa level and VTE incidence. Despite the evidence that weight-based enoxaparin dosing improves the likelihood that patients will achieve a target anti-Xa level, it is unclear what anti-Xa level correlates with decreased VTE risk. This is explicitly acknowledged by the College of American Chest Physicians in their VTE prophylaxis guidelines (3). ................
................